by American Physiological Society Graphical abstract. Credit: American Journal of Physiology-Renal Physiology (2022). DOI: 10.1152/ajprenal.00249.2022 The drug lasmiditan, which is used to treat migraines, shows promise as a possible treatment for acute kidney injury, according to a new study from the University of Arizona. The findings are published ahead of print in the American Journal of Physiology–Renal Physiology....
by UT Southwestern Medical Center Credit: Pixabay/CC0 Public Domain Triptans, a commonly prescribed class of migraine drugs, may also be useful in treating obesity, a new study by scientists at UT Southwestern suggests. In studies on obese mice, a daily dose of a triptan led animals to eat less food and lose weight over the...
by Judy George, Senior Staff Writer, MedPage Today January 20, 2021 The migraine prevention drug erenumab (Aimovig) was associated with elevated blood pressure (BP), an FDA analysis of postmarketing case reports suggested. Of 61 erenumab-linked hypertension cases submitted to the FDA Adverse Event Reporting System (FAERS), 41 were associated with a serious outcome according to regulatory criteria,...
